V ascular injury and subsequent thrombus formation are key events in the pathogenesis of several arterial diseases, including unstable angina pectoris, myocardial infarction, and stroke. 1 The blood fibrinolytic system, which functions to degrade intravascular fibrin, constitutes a critical response mechanism to arterial injury and thrombosis. Endogenously mediated fibrinolysis is initiated by t-PA and u-PA, enzymes that convert plasminogen to the fibrinolytic protease plasmin. 2 However, the rate and extent of thrombolysis after arterial injury can vary considerably in humans. In some individuals, arterial thrombi lyse spontaneously within several hours, whereas in others, thrombi fail to lyse, resulting in permanent vascular occlusion. 3 This phenomenon is of considerable clinical importance in the setting of acute myocardial infarction, because early restoration of normal coronary artery blood flow is strongly associated with improved survival, and even delayed thrombolysis appears to exert beneficial effects on cardiac function. 4, 5 However, the molecular determinants of the lysis of arterial thrombi, which are characterized by a high platelet content, are not well understood. Although plasminogen activators trigger activation of the fibrinolytic pathway, multiple cofactors, inhibitors, and proteases contribute to the regulation of vascular fibrinolysis. 2, 6 Several studies suggest that PAI-1, which inhibits fibrinolysis by binding irreversibly to the active site of t-PA and u-PA, is a major determinant of the resistance of platelet-rich clots to lysis by t-PA. [7] [8] [9] [10] [11] However, other studies suggest that PAI-1 plays only a minor role in regulating the lysis of platelet-rich clots. 12, 13 These contrasting results probably resulted from the variable concentrations of platelets, t-PA, PAI-1, and other factors that were used in different in vitro experiments. However, the concentrations of fibrinolytic components at sites of arterial injury are not well defined.
14 Therefore, in vivo experiments are necessary to examine the true function of PAI-1 in regulating thrombolysis at sites of arterial injury. The capacity to manipulate the mouse genome by gene targeting approaches has provided a powerful tool for studying protein function in vivo. 15, 16 Mice lacking PAI-1 have been genetically engineered, 17 and these animals exhibit a phenotype consistent with that observed in humans with PAI-1 deficiency. 18, 19 To address the role of PAI-1 in the regulation of arterial thrombolysis, we developed a murine model of arterial injury and thrombosis and used it to study both wild-type and PAI-1-deficient mice.
Methods

Animals
C57BL/6J mice were purchased from Jackson Laboratory, Bar Harbor, Me. PAI-1-deficient mice were generated by homologous recombination in embryonic stem cells, as described previously. 17 To eliminate potential effects of strain differences on experimental results, consecutive generations of mice carrying the null PAI-1 allele were backcrossed repeatedly to C57BL/6J mice. Only mice that were the product of five or more backcrosses to C57BL/6J were used in experiments comparing PAI-1-deficient (PAI-1 Ϫ/Ϫ) mice with wild-type C57BL/6J (PAI-1 ϩ/ϩ) mice. Genotyping of mice was performed by polymerase chain reaction analysis of tail DNA as described previously. 20 
Thrombosis Protocol
Mice (6 to 8 weeks old; weight, Ϸ25 g) were anesthetized by inhalation of 1% isoflurane and secured in the supine position under a dissecting microscope (Zeiss). A midline cervical incision was made, and the left common carotid artery was isolated by blunt dissection. FeCl 3 (Mallinckrodt Chemical) was used to induce vascular injury. 21 A 1ϫ2-mm strip of filter paper saturated with 10% FeCl 3 solution was applied to the adventitial surface of the surgically exposed carotid artery for 3.0 minutes, then removed. The surgical incision was sutured with 4 -0 monofilament, and the animal was returned to its cage. Operators were blinded to PAI-1 genotype while performing the thrombosis protocol. Twenty-four hours later, mice were anesthetized, and the injured carotid segments were isolated and perfusionfixed by manual injection of 4% formaldehyde (1.0 mL) into the heart via a 25-gauge needle. The injured carotid artery segment and Ϸ1 mm of proximal and 1 mm of distal uninjured artery were excised (total length of excised arterial segment, Ϸ4 mm), placed in formaldehyde fixative, and later embedded in paraffin for histological analyses.
Histological and Morphometric Analyses
To quantify the amount of thrombus present in carotid arteries 24 hours after injury, four evenly spaced transverse sections (distance between sections, Ϸ1 mm) were prepared from each paraffinembedded carotid artery and subjected to hematoxylin-eosin staining. Each transverse section was scored for the presence or absence of intraluminal thrombus. In addition, a computer-assisted planimetry program (Image-Pro Plus, Media Cybernetics) was used to measure the cross-sectional area of thrombus for each transverse section, and the mean of these values was calculated for each artery. Examiners were blinded to the genotype (ie, PAI-1 ϩ/ϩ or Ϫ/Ϫ) of specimens during all histological analyses. To determine the composition of thrombi, some carotid artery specimens were analyzed by transmission electron microscopy as described previously.
22
Platelet Aggregation Studies
Blood was collected into citrate anticoagulant from anesthetized mice by inferior vena cava puncture with a 25-gauge needle. PRP was prepared by centrifuging blood (120g for 6 minutes) at room temperature in a swing-out rotor. The platelet count of PRP was adjusted with citrated platelet-poor plasma to 2ϫ10 8 platelets/mL. Samples (200 L) of PRP were placed in 7.5ϫ55-mm siliconized flat-bottom tubes, and standard aggregometry was performed with a model PAP-4 aggregometer (Bio/Data Corp).
Statistical Analyses
Data are presented as meanϮSD. The generalized estimating equations method was used to determine whether a significant difference existed between experimental groups in the prevalence of intraluminal thrombus. 23 The Wilcoxon rank-sum test was used to determine whether a significant difference existed in mean thrombus crosssectional areas between experimental groups. Student's unpaired t test was used to compare in vitro aggregation of wild-type and PAI-1-deficient platelets.
Results
Murine Model of Acute Arterial Injury
We performed a series of studies to determine the feasibility of using mice to study arterial thrombosis and thrombolysis. The common carotid artery was selected for analysis because it was easily approached via a midline cervical incision. After performing the procedure on 3 to 5 mice, operators could routinely isolate the carotid artery in Ͻ10 minutes. We used topical application of FeCl 3 to the exposed carotid artery to induce vascular injury and thrombosis. 21 Completely occlusive carotid artery thrombosis was well tolerated by mice, presumably because of collateral cerebral blood flow provided by the contralateral carotid artery. After recovery from anesthesia, mice appeared healthy, demonstrating normal ambulation, feeding, and grooming. The operative mortality rate of carotid artery surgery was Ͻ5%. Fig 1 demonstrates the use of Whatman 1 filter paper to apply FeCl 3 to the arterial surface. Control experiments performed in Ͼ50 wild-type mice revealed that 10% FeCl 3 induced completely occlusive thrombosis within 30 minutes (determined by visual inspection of the artery under the dissecting microscope) in Ͼ90% of mice, whereas application of filter paper alone (ie, no FeCl 3 ) to carotid arteries did not induce thrombosis. To determine the composition of thrombi induced by FeCl 3 , injured carotid artery segments were perfusion-fixed immediately after induction of thrombosis, excised, and examined histologically. Light microscopic analysis of hematoxylin-eosin-stained specimens Figure 1 . Induction of vascular injury in murine carotid artery. A 1ϫ2-mm strip of filter paper saturated with 10% FeCl 3 was applied to surface of surgically exposed left carotid artery for 3 minutes, as described in "Methods." Forceps elevate carotid artery, which is viewed through a dissecting microscope (magnification ϫ16).
Selected Abbreviations and Acronyms
PAI-1 ϭ plasminogen activator inhibitor-1 PRP ϭ platelet-rich plasma t-PA ϭ tissue plasminogen activator u-PA ϭ urokinase plasminogen activator from 10 consecutive mice revealed that thrombus composition was uniform from animal to animal (Fig 2A) . Transmission electron microscopy confirmed that thrombi consisted predominantly of dense platelet aggregates (Fig 2B) , consistent with the composition of arterial thrombi observed in humans and large-animal thrombosis models.
Application of Carotid Injury Model to PAI-1-Deficient Mice
To examine the role of PAI-1 in regulating endogenously mediated arterial thrombolysis, we applied the FeCl 3 model to wild-type (PAI-1 ϩ/ϩ) and PAI-1-deficient (PAI-1 Ϫ/Ϫ) mice. Twenty-two PAI-1 ϩ/ϩ and 14 age-and sex-matched PAI-1 Ϫ/Ϫ mice were studied. Each group was subjected to identical carotid artery injury with 10% FeCl 3 as described in "Methods." There was no difference in operative bleeding between the two experimental groups. Twenty-four hours later, the injured carotid segments were perfusion-fixed and excised. Examiners were blinded to PAI-1 genotype during all evaluations of tissue samples. To determine whether the amount of residual intraluminal thrombus differed between experimental groups, each segment of injured carotid artery was cross-sectioned at four evenly spaced intervals as described in "Methods," and transverse sections were prepared for histological analysis (Fig 3) . Residual thrombus (either completely or partially occlusive) was detected in 55 of 85 sections (64.7%) obtained from PAI-1 ϩ/ϩ mice, compared with 19 of 56 sections (33.9%) from PAI-1 Ϫ/Ϫ mice (Pϭ.009, Fig 4A) . The cross-sectional area of thrombus was measured for each transverse section by computer-assisted planimetry, and the mean thrombus area for each artery was calculated (Fig 4B) . Mean residual thrombus area was 0.033Ϯ0.027 mm 2 (95% CI, 0.022 to 0.044 mm 2 ) in PAI-1 ϩ/ϩ mice versus 0.016Ϯ0.015 mm 2 (95% CI, 0.008 to 0.024 mm 2 ) in PAI-1 Ϫ/Ϫ mice (Pϭ.048). Subgroup analysis of patent and occluded vessels revealed an equal proportion of patent arteries in both groups (9 of 22 PAI-1 ϩ/ϩ mice versus 6 of 14 PAI-1 Ϫ/Ϫ mice). However, significantly less residual mural thrombus was observed in patent vessels from PAI-1 Ϫ/Ϫ mice than in those from PAI-1 ϩ/ϩ mice (0.001Ϯ0.002 versus 0.011Ϯ0.015 mm 2 , respectively, PϽ.05). Similarly, increased thrombus was present in occluded vessels from PAI-1 ϩ/ϩ mice compared with PAI-1 Ϫ/Ϫ mice (0.052Ϯ0.021 versus 0.027Ϯ0.010 mm 2 , respectively, PϽ.05). The significant difference in residual thrombus observed between wild-type and PAI-1-deficient mice 24 hours after injury could be explained by reduced thrombus formation and/or by enhanced thrombolysis in PAI-1 Ϫ/Ϫ mice. To address this issue, we studied thrombus generation after vascular injury in PAI-1 ϩ/ϩ (nϭ8) and PAI-1 Ϫ/Ϫ (nϭ4) mice. Mice were subjected to arterial injury with 10% FeCl 3 for 3 minutes. Thereafter, a miniature Doppler flow probe (model 0.5VB, Transonic Systems) that interfaced with a Transonic model T106 flowmeter was applied to the carotid artery, and blood flow was recorded with a computerized data acquisition program (WinDaq, DATAQ Instruments). All 4 vessels of PAI-1 Ϫ/Ϫ mice occluded within 30 minutes of initiation of injury, whereas 7 of 8 vessels from PAI-1 ϩ/ϩ mice occluded within 30 minutes. These results suggested that PAI-1 Ϫ/Ϫ mice did not exhibit a major defect in thrombus formation after injury compared with PAI-1 ϩ/ϩ mice. Because several minutes were necessary to properly position the flow probe on the artery, precise determination of the time of arterial occlusion was not possible in 7 of 12 mice studied, because the vessel had already thrombosed by the time the flow probe was properly positioned. Recorded times to occlusion after initiation of injury were Ͻ7.5, Ͻ9.5, 15.5, and 21 minutes in PAI-1 Ϫ/Ϫ mice versus Ͻ6.0, Ͻ6.5, Ͻ8.5, Ͻ15, Ͻ15, 17, and 16 minutes in PAI-1 ϩ/ϩ mice (blood flow was monitored for a total of 45 minutes after injury in the 1 PAI-1 ϩ/ϩ animal that did not develop occlusive carotid artery thrombosis). To determine whether PAI-1 deficiency was associated with a primary defect in platelet aggregation, pooled platelet-rich plasma was prepared from PAI-1 ϩ/ϩ mice (nϭ2) and PAI-1 Ϫ/Ϫ mice (nϭ2), and in vitro platelet aggregation studies were performed (Fig 5) . There was no significant difference in ADP-induced aggregation between PAI-1 ϩ/ϩ and PAI-1 Ϫ/Ϫ platelets (64.5Ϯ4.9% in PAI-1 ϩ/ϩ mice versus 58Ϯ4.2% in PAI-1 Ϫ/Ϫ mice, Pϭ.29). We also compared thrombus composition in PAI-1 ϩ/ϩ and PAI-1 Ϫ/Ϫ mice, because this parameter is an important determinant of the rate of clot lysis. 24 No gross differences were observed-ie, all thrombi appeared to be platelet-rich. Because leukocytes migrate into thrombi within 24 hours after initial formation and leukocyte proteases, such as elastase, degrade fibrin, 3, 25 we compared thrombus leukocyte density between experimental groups. No significant differences were observed (1.4Ϯ0.4 leukocytes per high-power field in PAI-1 ϩ/ϩ mice versus 1.4Ϯ0.4 leukocytes per high-power field in PAI-1 Ϫ/Ϫ mice). Similarly, no differences in the histological appearance of injured arterial walls was observed between PAI-1 ϩ/ϩ and PAI-1 Ϫ/Ϫ mice. Topical application of FeCl 3 produced full-thickness, noncircumferential vascular injury (Fig 3) . Medial cross-sectional area, an index of the severity of vessel injury, did not differ between groups (0.015Ϯ0.0026 mm 2 in PAI-1 ϩ/ϩ mice versus 0.015Ϯ0.0041 mm 2 in PAI-1 Ϫ/Ϫ mice).
Modification of Injury Model for Study of Thrombus Formation
Our experiments with the vascular flow probe suggested that the carotid artery model would prove useful for quantitatively studying blood flow and thrombus formation in mice. Such a system would be useful in the analysis of mice with genetic modifications in factors that regulate carotid artery blood flow (eg, adrenergic receptors) or platelet deposition after arterial injury (eg, platelet or endothelial cell integrins). Carotid artery blood flow in anesthetized mice (nϭ14) was 1.1Ϯ0.7 mL/min. Mice could be maintained under general anesthesia for at least 1 hour with stable heart and respiratory rates and stable carotid artery blood flows. As shown in Fig 6A, high-quality flow tracings could be obtained from the mouse carotid artery. To better study thrombosis after injury, we modified our protocol to allow induction of vascular injury while the flow probe was positioned on the artery. This was done with a smaller strip of filter paper (0.5ϫ1.0 mm) saturated with higher concentrations of FeCl 3 (25% to 50%) applied proximal to the flow probe. Mean time to occlusion was 13.6Ϯ5.1 minutes after 25% FeCl 3 injury (nϭ4) and 5.6Ϯ4.9 minutes after 50% FeCl 3 injury (nϭ5). Cyclic flow reductions, which result from repetitive formation and embolization of thrombi at sites of vascular injury, 26 were observed (Fig 6B) . These observations indicate that the carotid artery model demonstrates several features observed in large-animal models and therefore should prove useful in murine studies of blood flow regulation and thrombosis after vascular injury.
Discussion
Platelet-rich thrombi are more resistant to lysis by t-PA than platelet-poor thrombi. 24 However, the mechanisms underlying this phenomenon are not well defined. In this report, we studied the role of PAI-1 in regulating the endogenous clearance of platelet-rich arterial thrombi in mice. PAI-1 is abundant in platelets, and its secretion from vascular endothelial cells is stimulated by factors released from activated platelets. 27 Several in vitro studies suggest that PAI-1 is the dominant factor underlying platelet-mediated clot lysis resis- tance. 7, 8, 10, 11 However, other studies have concluded that PAI-1 plays only a minor role in inhibiting the lysis of platelet-rich clots. 12, 13 These discordant results are probably explained by the different concentrations of t-PA and platelets that were used in different in vitro studies, which do not necessarily reflect those attained in vivo at sites of arterial injury. Furthermore, in vitro experiments do not account for the role of the vascular wall in the regulation of clot lysis. Earlier studies examining the role of PAI-1 in regulating clot lysis in vivo involved the injection of preformed clots into veins or the injection of whole blood/ thrombin mixtures into isolated arterial segments. 7,28 -31 Therefore, the role of PAI-1 in regulating the clearance of plateletrich thrombi that form in response to arterial injury has not been adequately addressed. Our study has demonstrated that compared with wild-type mice, mice lacking PAI-1 exhibit a significant reduction in intraluminal thrombus 24 hours after arterial injury. These results suggest that PAI-1 inhibits the lysis of platelet-rich thrombi that form in vivo in response to arterial injury and are consistent with our earlier studies demonstrating that in vitro clots containing human PAI-1-deficient platelets lyse more rapidly than clots with normal PAI-1 content. 32 In addition to delaying restoration of blood flow in occluded arteries, inhibition of arterial thrombolysis by PAI-1 would be expected to retard clearance of nonocclusive mural thrombi. Mural arterial thrombi appear to contribute to the development of atherosclerosis, because they may be incorporated into developing lesions or serve as a source of platelet-derived growth factors that stimulate smooth muscle cell proliferation. 33 Therefore, our results are consistent with the recent report that PAI-1 deficiency protects apolipoprotein E-deficient mice from the development of atherosclerosis. 34 Although the results of murine studies must be extended with caution to human diseases, our studies relate to the variable thrombolysis that is observed in humans with acute coronary artery occlusion. It is not well understood why spontaneous thrombolysis is observed in some individuals but not in others. Plasma PAI-1 concentrations vary widely in the normal population, 35, 36 which may account, at least partially, for the variable degree of endogenous thrombolysis that is observed after arterial thrombosis in humans.
Detection of less residual thrombus after injury in PAI-1 Ϫ/Ϫ mice does not necessarily imply enhanced thrombolysis compared with PAI-1 ϩ/ϩ mice, because it was not possible in our study to confirm equal amounts of thrombus deposition in each group. However, studies in which a flow probe was used to confirm thrombus formation did not suggest a diminished tendency to form thrombi in PAI-1 Ϫ/Ϫ mice. In addition, in vitro studies revealed no significant difference in platelet aggregation between experimental groups. Similarly, histological analysis of injured carotid segments did not reveal differences in thrombus composition or the extent of injury between groups. Carmeliet et al 30 demonstrated that PAI-1 Ϫ/Ϫ mice exhibit normal tail bleeding times and normal blood loss after amputation of the caecum compared with PAI-1 ϩ/ϩ mice. Together, these observations suggest that there is no significant difference in clot formation after injury between PAI-1 ϩ/ϩ and PAI-1 Ϫ/Ϫ mice and that the reduction in residual thrombus that we observed 24 hours after injury in PAI-1 Ϫ/Ϫ mice resulted from enhanced thrombolysis. However, because thrombosis and thrombolysis can occur concurrently in vivo, 7 it is possible that diminished thrombus formation also contributed to our results. Regardless of mechanism, our studies demonstrate the important role of PAI-1 in determining the net amount of platelet-rich thrombus present in arteries after injury.
Characterization of FeCl 3 -Induced Thrombosis and Comparison With Other Models
In addition to studying the biological function of PAI-1, a goal of our study was to develop a reliable model of arterial injury and thrombosis in mice. Kurz et al 21 first described the use of FeCl 3 to induce arterial thrombosis in rats weighing 375 to 450 g. Our studies demonstrate that this method can be applied effectively to animals weighing Ͻ25 g and that FeCl 3 produces platelet-rich thrombi. The FeCl 3 model exhibits several features that suggest that it will prove useful for studying the molecular determinants of arterial thrombosis and thrombolysis in transgenic mice. It allows for uniform injury from animal to animal, because the concentration of FeCl 3 , the size of the arterial segment being injured, and the duration of injury can be precisely controlled. Because FeCl 3 does not produce circumferential vessel injury, it allows induction of thrombosis without complete destruction of vascular cells that mediate subsequent thrombolysis. Carotid artery blood flow can be monitored accurately in mice, and complete vascular occlusion is well tolerated because of collateral blood flow. In addition, the relevance of the murine model to large-animal thrombosis models is supported by the fact that cyclic flow variations are observed in the mouse carotid artery after FeCl 3 injury. 26 A variety of methods have been used to study thrombosis in rodents. These include application of electrical, mechanical, and other forms of energy to different vascular sites, intravenous injection of clots formed in vitro, and injection of blood/thrombin mixtures into isolated vascular segments. 31, [37] [38] [39] [40] [41] [42] Only a few of these models have been applied to mice. Carmeliet et al 30 and Palabrica et al 43 modified the hamster pulmonary embolism model of Stassen et al 37 to study the regulation of thrombolysis in mice, whereas Pierangeli 44 used "pinch" injury to induce femoral vein thrombosis. In contrast to these experimental systems, our model includes the key components of arterial injury and high-velocity laminar flow that are necessary to generate platelet-rich thrombi. The mechanism by which FeCl 3 induces thrombosis is not well defined. Iron induces formation of highly reactive oxidant species and potentiates the sensitivity of endothelial cells to oxidant damage. 45 Recent studies indicate that FeCl 3 induces thrombosis by triggering expression of tissue factor, a major determinant of thrombosis at sites of atherosclerotic plaque rupture. 46, 47 Carmeliet et al 48 used perivascular electric injury to study vascular wound healing and neointima formation in mouse femoral arteries. Induction of thrombi by electrical injury may depend on the generation of reactive iron species, because only iron-containing electrodes efficiently cause thrombus formation. 21 Therefore, it is possible that topical FeCl 3 and electrical current delivered by iron-containing electrodes induce vascular injury by similar mechanisms.
In summary, we have developed a murine model of carotid artery injury that we have used to demonstrate the important role of PAI-1 in regulating the acute clearance of arterial, platelet-rich thrombi. The model is easy to perform and does not require the use of specialized surgical techniques or equipment to induce vascular injury. Because many other components of the murine blood coagulation and fibrinolytic systems have been modified by gene targeting approaches, 49 -55 this model should prove useful for studying the function of other blood coagulation and fibrinolysis factors within the distinct environment of the acutely injured artery.
